Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Am J Surg Pathol. 2022 Nov 28;47(2):172–182. doi: 10.1097/PAS.0000000000002002

Table 2.

Changes in CNB diagnoses based on WHO diagnostic categories between outside (y-axis) and MSK (x-axis).

In-House/MSK Diagnosis Total
DUCTAL LOBULAR mIC IBC PAPILLOMA PAPILLARY CARCINOMA Fibroadenoma Fibroepithelial tumors
Benign breast Radial scar/ complex sclerosing lesion FEA ADH DCIS cLCIS/ ALH Pleomorphic/ florid LCIS without atypia with ADH with DCIS without invasion with mIC invasive
Outside Diagnosis DUCTAL Benign breast 12 2 1 1 1 17
Radial scar/ complex sclerosing lesion 1 1 1 1 4
FEA 6 3 1 10
ADH 11 1 17 3 2 2 36
DCIS 10 3 2 17 4 1 1 38
LOBULAR cLCIS/ALH 3 1 4
Pleomorphic/ florid LCIS 0
mIC 0
IBC 1 1 2 1 5
PAPILLOMA without atypia 5 2 4 2 3 16
with ADH 1 1 2
with DCIS 2 2
PAPILLARY CARCINOMA without invasion 2 1 3
with mIC 1 1
invasive 1 1
Fibroadenoma 2 2 4
Fibroepithelial tumors 1 1 2
Total 25 2 1 33 21 9 2 18 11 3 6 0 6 2 0 4 2 145 *

ADH = atypical ductal hyperplasia, ALH = atypical lobular hyperplasia, cLCIS = classic lobular carcinoma in situ, DCIS = ductal carcinoma in situ, FEA = flat epithelial atypia, IBC = invasive breast carcinoma, mIC = microinvasive carcinoma.

*

Does not include one case of skin adnexal tumor and one case of spindle cell sarcoma.